Authors

Latest:

Expert Discusses Value of Venetoclax After BCR Inhibition in CLL

Jeffrey Jones, MD, discusses promising early data for venetoclax in chronic lymphocytic leukemia after progression on BCR-pathway inhibitors, as well as the next steps with the research.

Elizabeth M. Gore, MD

Latest:

Dr. Gore on Toxicity in Elderly Lung Cancer Patients

Dr. Elizabeth Gore, from the Medical College of Wisconsin, on Toxicity in Elderly Lung Cancer Patients

Elizabeth M. Swisher, MD

Latest:

Dr. Swisher on the Limitations of HRD as a Biomarker in Ovarian Cancer

Elizabeth M. Swisher, MD, discusses the limitations of homologous recombination deficiency as a biomarker of response in ovarian cancer based on findings from the phase III VELIA trial.

Elizabeth Mittendorf Dana-Farber

Elizabeth Mittendorf, MD

Latest:

Dr. Mittendorf on Vaccines as Prevention for Breast Cancer

Elizabeth A. Mittendorf, MD, PhD, associate professor in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center, discusses the possibility of using vaccines as a preventative measure for breast cancer, particularly to fight recurrence.

Elizabeth Mittendorf, MD, PhD, MHCM

Elizabeth Mittendorf, MD, PhD, MHCM, is the Robert and Karen Hale Distinguished Chair in Surgical Oncology and the vice chair for research in the Department of Surgery at the Brigham and Women's Hospital; co-leader of the Breast Program and director of the Breast Immuno-Oncology Program at the Dana-Farber Brigham Cancer Center; co-leader of the Parker Institute for Cancer Immunotherapy at the Dana-Farber Cancer Institute; and a professor of surgery at Harvard Medical School

Latest:

Collaborative Structural Reforms Represent a Way Forward for Oncology Innovations: With Elizabeth Mittendorf, MD, PhD, MHCM

Dr Mittendorf shares how ASCO plans to address the implications of federal research funding cuts and how structural reforms may bolster oncology progress.

Elizabeth Petri Henske, MD

Latest:

Dr. Henske on the Potential Role of Glutathione in Chromophobe RCC

Elizabeth Petri Henske, MD, discusses the potential role of glutathione in chromophobe renal cell carcinoma.

Elizabeth Plimack, MD

Latest:

Future Directions in Renal Cell Carcinoma

Panelists discuss emerging research directions and novel therapeutic combinations poised to shape the next generation of renal cell carcinoma management.

Elizabeth R. Plimack, MD, Fox Chase Cancer Center

Elizabeth R. Plimack, MD, MS, FASCO

Latest:

Key Takeaways on Updates in Bladder Cancer

Elizabeth Plimack, MD, MS, FASCO, recaps the discussion with key takeaways on recent updates in bladder cancer.

Elizabeth R. Plimack, MD, MS, Fox Chase Cancer Center

Latest:

Selecting Optimal Therapy for Advanced Non-Clear Cell RCC

Focusing their discussion on a real-world patient scenario, expert panelists discuss treatment options in the setting of advanced non-clear cell renal cell carcinoma.

Elizabeth Swisher, MD

Latest:

Dr. Swisher on the Phase III VELIA Results in Ovarian Cancer

Elizabeth M. Swisher, MD, discusses results from the phase III VELIA/GOG-3005 trial in ovarian cancer.

Elizabeth Whittington

Latest:

Long-term Aspirin Use Decreases Risk of GI Cancers, Especially Colorectal

A recent study joins a body of evidence suggesting that long-term, regular aspirin use is associated with a reduced risk for cancer, with the most dramatic reduction being seen in colorectal cancer incidence.

Ellen K. Ritchie, MD, New York Presbyterian Hospital

Ellen K. Ritchie, MD, Weill Cornell Medicine

Ellen T. Matloff, MS, CGC

Latest:

Ellen T. Matloff on Changes to the Field of Genetic Testing

Ellen T. Matloff, MS, CGC, director, Yale Cancer Genetic Counseling Program at the Yale School of Medicine/Yale Cancer Center, gives an overview of the recent changes to the field of genetic testing.

Ellie Leick

Latest:

Navigating COVID-19 Challenges to Provide Optimal Cancer Care

Gilberto De Lima Lopes, MD, discusses the impact of COVID-19 on his practice and how he is coping with the changes caused by the pandemic.

Ellyn Matthews, PhD

Latest:

Ellyn Matthews Addresses Misconceptions About Sleep Disturbances

Ellyn Matthews, PhD, RN, AOCNS, CBSM, who holds the Elizabeth Stanley Cooper Endowed Chair in Oncology Nursing at the University of Arkansas for Medical Sciences, addresses common misconceptions that patients with cancer have about sleep disturbances.

Emad Kandil, MD

Latest:

Dr. Kandil on Minimally Invasive Surgical Techniques

Emad Kandil, MD, Chief of Endocrine Surgery at the Tulane University School of Medicine, discusses advances in surgical procedures.

Emad Kandil, MD, FACS, FACE

Latest:

Robotic Surgery Represents a Notable Advance in Thyroid Cancer Care

Amid a rising incidence of thyroid cancer, endocrine surgeons have increasingly explored minimally invasive approaches for operating on patients with the disease.